• 検索結果がありません。

透明帯糖蛋白質合成ペプチドを抗原としたエゾシカ避妊ワクチン開発に関する研究

N/A
N/A
Protected

Academic year: 2021

シェア "透明帯糖蛋白質合成ペプチドを抗原としたエゾシカ避妊ワクチン開発に関する研究"

Copied!
6
0
0

読み込み中.... (全文を見る)

全文

(1)

Degree) Issue Date 2014-03-13 Type 博士論文 Version none URL http://hdl.handle.net/20.500.12099/49037 ※この資料の著作権は、各資料の著者・学協会・出版社等に帰属します。

(2)

Ꮫ ఩ ㄽ ᩥ せ ⣙

   Ặ    ྡ ᑠᯘ ᜏᖹ    㢟    ┠㏱᫂ᖏ⢾⺮ⓑ㉁ྜᡂ࣌ࣉࢳࢻࢆᢠཎ࡜ࡋࡓ࢚ࢰࢩ࢝㑊ዷ࣡ ࢡࢳࣥ㛤Ⓨ࡟㛵ࡍࡿ◊✲  ㏆ᖺ໭ᾏ㐨࡟࠾࠸࡚㸪࢚ࢰࢩ࢝ಶయᩘࡢቑຍࡀ♫఍ⓗၥ㢟࡜࡞ࡗ࡚࠸ࡿࠋ࢚ ࢰࢩ࢝ၥ㢟ࡣ㎰ᯘᴗ⿕ᐖ㸪⏕ែᏛⓗ⿕ᐖ㸪஺㏻஦ᨾ࡞࡝ከᵝ࡞ഃ㠃ࢆᣢࡗ࡚࠾ ࡾ㸪࠸ࡎࢀࡶ῝้࡞≧ែ࡛࠶ࡿࠋ⾜ᨻࡣ㥑㝖ࢆ୺య࡜ࡋࡓᑐ⟇ࢆㅮࡌ࡚࠸ࡿࡀ㸪 ࣁࣥࢱ࣮ࡢ୙㊊ࡸ࢚ࢰࢩ࢝ࡢᏛ⩦࡟ࡼࡿ㥑㝖ຠ⋡ࡢపୗ࡞࡝࠿ࡽ┠ᶆࡢᤕ⋓㢌 ᩘ࡟⮳ࡽࡎ㸪౫↛࡜ࡋ࡚῝้࡞⿕ᐖࡀᣢ⥆ࡋ࡚࠸ࡿࠋ࢚ࢰࢩ࢝ࡣ෤Ꮨࡢ኱㔞Ṛ ࡜㸪ࡑࢀ࡟ぢྜ࠺᪲┒࡞⦾Ṫຊࡢ㸰⪅ࡢࣂࣛࣥࢫࡀಖࡓࢀࡿ஦࡛ಶయᩘࡀಖࡓ ࢀ࡚ࡁࡓࠋࡋ࠿ࡋ㏆ᖺ㸪෤Ꮨࡢ㣵ࡸ㉺෤ᆅࡀቑ࠼㸪Ṛஸᩘࡀῶࡗࡓࡇ࡜࡟ࡼࡾ㸪 ⌧ᅾࡢࡼ࠺࡞⇿Ⓨⓗ࡞ቑຍ࡟⮳ࡗ࡚࠸ࡿ࡜⪃࠼ࡽࢀࡿࠋ⌧ᅾ⾜ࢃࢀ࡚࠸ࡿᤕ⋓ ࡣ⎔ቃせᅉ࡟ᑐࡍࡿᑐ⟇࡛࠶ࡿࡀ㸪ᢪ࠼࡚࠸ࡿㄢ㢟ࡶከ࠸ࠋࡑࡇ࡛⌧⾜ࡢᑐ⟇ ࡜㑊ዷ࣡ࢡࢳࣥࢆ⏝࠸ࡓ⦾Ṫᢚไ࡟ࡼࡿ⏕⌮ⓗせᅉᑐ⟇࡜ྜࢃࡏࡿ஦࡛ࡼࡾຠ ⋡ⓗ࡞ಶయᩘ⟶⌮ࡀྍ⬟࡟࡞ࡿ࡜⪃࠼ࡽࢀࡿࠋ  㑊ዷ࣡ࢡࢳࣥ࡟㛵ࡍࡿ◊✲ࡣᾏእ࡟࠾࠸࡚ࡣከࡃ⾜ࢃࢀ࡚࠾ࡾ㸪⢭〇ࡋࡓࣈ ࢱ㏱᫂ᖏ⢾ࢱࣥࣃࢡ㉁ࡣከࡃࡢື≀✀࡟࠾࠸࡚㑊ዷຠᯝࡀሗ࿌ࡉࢀ࡚࠸ࡿࠋࡋ ࠿ࡋ㸪ᮏ◊✲࡛ࡣ㸪ಶయᩘ⟶⌮࡟ྥࡅࡓ㔝እ㐺⏝ࢆ๓ᥦ࡜ࡋ࡚࠸ࡿࡓࡵ㸪ᤕ⋓ ࡋ࡚ᢞ୚ࡍࡿ࣡ࢡࢳ࡛ࣥࡣ࡞ࡃ⢓⭷ᢞ୚➼࡛ከᩘࡢಶయ࡟ຠ⋡ⓗ࡟ᢞ୚ࡍࡿᚲ せࡀ࠶ࡾ㸪ࡑࢀࡽࡢ◊✲ࢆࡑࡢࡲࡲ㐺⏝ࡍࡿࡇ࡜ࡣ࡛ࡁ࡞࠸ࠋࡉࡽ࡟ከᩘಶయ ࡬ࡢᢞ୚࡟㝿ࡋ࡚ᑐ㇟࡜ࡋ࡞࠸ື≀࡬ࡢᙳ㡪ࢆ᭱ᑠ㝈࡟ࡋ࡞ࡃ࡚ࡣ࡞ࡽࡎ㸪✀ ≉␗ᛶࡢ㧗࠸ᢠཎࢆ⏝࠸ࡿᚲせࡀ࠶ࡿࠋࡑࡇ࡛ᮏ◊✲࡛ࡣ㸪ᢠཎࡢ⠊ᅖࢆᑠࡉ ࡃࡍࡿࡇ࡜࡟ࡼࡿ✀≉␗ᛶࡢ☜ಖ࠾ࡼࡧ⢓⭷ᢞ୚ᆺ࣡ࢡࢳࣥ࡬ࡢⓎᒎᛶࢆ⪃៖ ࡋ࡚ྜᡂ࣌ࣉࢳࢻࢆᢠཎ࡜ࡋ࡚㸪㏱᫂ᖏ⢾ࢱࣥࣃࢡ㉁ࡢ୰࡛㧗࠸✀≉␗ᛶࢆ᭷ ࡋ࠿ࡘ㑊ዷຠᯝࢆࡶࡓࡽࡍ㡿ᇦࢆ㑅ᐃࡋ㸪㑊ዷ࣡ࢡࢳࣥ࡜ࡋ࡚ࡢ᭷⏝ᛶࢆ᳨ウ ࡍࡿࡇ࡜࡜ࡋࡓࠋ  ➨㸰❶࡛ࡣ㸪ࣈࢱ㏱᫂ᖏ⢾⺮ⓑ㉁ =3% ⣽⬊࢚ࣆࢺ࣮ࣉ࡟ᑐࡍࡿ࢚ࢰࢩ࢝࡟࠾ ࡅࡿᢠయ⏘⏕࠾ࡼࡧᢠయࡢᶵ⬟ࢆ᳨ウࡋࡓࠋࣈࢱ㏱᫂ᖏ⢾⺮ⓑ㉁ࡣ =3㸪=3㸪 =3 ࡟ศࡅࡽࢀࡑࡢ࠺ࡕ =3 ࡢ % ⣽⬊࢚ࣆࢺ࣮ࣉ㓄ิࡀ᫂ࡽ࠿࡟࡞ࡗ࡚࠾ࡾ㸪࢜ ࢪࣟࢪ࢝࡟࠾࠸࡚ࡑࡢ㓄ิ࡟ᇶ࡙࠸ࡓྜᡂ࣌ࣉࢳࢻ࡛ᢠయ౯ࡢୖ᪼ࡀㄆࡵࡽࢀ ࡓሗ࿌ࡀ࠶ࡿࠋࡋ࠿ࡋࡑࡢ◊✲࡛ࡣᢠయࡢ⤖ྜ࡞࡝ࡑࡢᚋࡢゎᯒࡣࡋ࡚࠾ࡽࡎ㸪 ྜᡂ࣌ࣉࢳࢻࡢ㑊ዷຠᯝࡣ☜࠿ࡵࡽࢀ࡚࠸࡞࠸ࠋࡑࡇ࡛ᮏ◊✲࡛ࡣ㸪ࣈࢱࡢ =3%

(3)

ᯝ㸪ᢠయ౯ࡢⴭࡋ࠸ୖ᪼ࡀㄆࡵࡽࢀࡓࡀ㸪ࡑࡢᢠయࡣ㸪ࣈࢱ㏱᫂ᖏ࡟ࡣ⤖ྜࡋ ࡓࡀ㸪࢚ࢰࢩ࢝㏱᫂࡟ࡣ⤖ྜࡋ࡞࠿ࡗࡓࠋࡲࡓ㸪 㢌ࡢᢞ୚ಶయࡢ࠺ࡕ  㢌࡛ዷ ፎࡀㄆࡵࡽࢀࡓࠋࡇࢀࡽࡢ⤖ᯝ࠿ࡽࣈࢱ =3㸯% ⣽⬊࢚ࣆࢺ࣮ࣉ࡜࢚ࢰࢩ࢝ࡢ࢚ ࣆࢺ࣮ࣉࡢ㓄ิࡀ␗࡞ࡗ࡚࠸ࡿ࡜⪃࠼ࡽࢀ㸪✀≉␗ᛶࡀ♧၀ࡉࢀࡓࠋ  ➨㸱❶࡛ࡣ㸪࢚ࢰࢩ࢝㏱᫂ᖏ⢾⺮ⓑ㉁ % ⣽⬊࢚ࣆࢺ࣮ࣉ࡟ᑐࡍࡿᢠయࡢ㏱᫂ ᖏ࡬ࡢ⤖ྜ࡜ࡑࡢ✀≉␗ᛶ࡟ࡘ࠸᳨࡚ウࡋࡓࠋ࢚ࢰࢩ࢝ࡢ =3 ࡢ㑇ఏᏊ㓄ิࡢ ྠᐃࢆ⾜࠸㸪࢚ࢰࢩ࢝࡟࠾ࡅࡿ =3% ⣽⬊࢚ࣆࢺ࣮ࣉ㡿ᇦࡢ࢔࣑ࣀ㓟㓄ิ࡟ᇶ࡙ ࡃྜᡂ࣌ࣉࢳࢻࢆసᡂࡋࡓࠋྜᡂ࣌ࣉࢳࢻࢆ࢘ࢧࢠ࡟ච␿ࡋ࡚సᡂࡉࢀࡓᢠయ ࢆ⏝࠸࡚ච␿ᰁⰍ࠾ࡼࡧయእཷ⢭㜼ᐖヨ㦂ࢆ⾜࠸㸪ᢠయࡢᶵ⬟࠾ࡼࡧ✀≉␗ᛶ ࢆㄪ࡭ࡓࠋࡑࡢ⤖ᯝ㸪ᢠయࡣ࢚ࢰࢩ࢝㏱᫂ᖏࢆ✀≉␗ⓗ࡟ㄆ㆑ࡋ㸪ࣈࢱ࠾ࡼࡧ ࢘ࢩࡢ㏱᫂ᖏࡣㄆ㆑ࡋ࡞࠿ࡗࡓࠋࡑࡢࡇ࡜࠿ࡽྜᡂ࣌ࣉࢳࢻࢆᢠཎ࡜ࡋ࡚ᶆⓗ ࢆ୍ࡘࡢ࢚ࣆࢺ࣮ࣉ࡟ࡲ࡛⤠ࡾ㎸ࡴࡇ࡜࡛㸪✀≉␗ⓗ࡟㏱᫂ᖏࢆㄆ㆑ࡍࡿᢠయ ࡀᚓࡽࢀࡿࡇ࡜ࡀ᫂ࡽ࠿࡟࡞ࡗࡓࠋ  ➨㸲❶࡛ࡣ㸪࢚ࢰࢩ࢝࡟ᑐࡍࡿ࢚ࢰࢩ࢝㏱᫂ᖏ⢾⺮ⓑ㉁ % ⣽⬊࢚ࣆࢺ࣮ࣉྜ ᡂ࣌ࣉࢳࢻᢞ୚࡟ࡼࡿᢠయ⏘⏕࠾ࡼࡧᢠయࡢᶵ⬟ࢆ᳨ウࡋࡓࠋࡑࡇ࡛㸪⮬ᕫᢠ ཎ࡛࠶ࡿ࢚ࢰࢩ࢝ =3% ⣽⬊࢚ࣆࢺ࣮ࣉྜᡂ࣌ࣉࢳࢻࢆᢞ୚ࡍࡿࡇ࡜࡛࢚ࢰࢩ࢝ ࡟࠾࠸࡚ࡶ᭷ຠ࡞ᢠయ⏘⏕ࡀᚓࡽࢀࡿࡇ࡜ࢆ☜࠿ࡵࡿࡓࡵ㸪㣫⫱ୗ࢚ࢰࢩ࢝ࢆ ⏝࠸ࡓච␿ヨ㦂࠾ࡼࡧᚓࡽࢀࡓᢠయࢆ⏝࠸ࡓච␿ᰁⰍࢆ⾜ࡗࡓࠋࡑࡢ⤖ᯝ㸪ᢠ యࡣ࢚ࢰࢩ࢝㏱᫂ᖏࢆ✀≉␗ⓗ࡟ㄆ㆑ࡋ㸪ࣈࢱ࠾ࡼࡧ࢘ࢩࡢ㏱᫂ᖏࡣㄆ㆑ࡋ࡞ ࠿ࡗࡓࠋࡑࡢࡇ࡜࠿ࡽ㸪⮬ᕫᢠཎࡢ࢔࣑ࣀ㓟㓄ิ࡟ᇶ࡙ࡃྜᡂ࣌ࣉࢳࢻ࡛࠶ࡗ ࡚ࡶ㸪࢚ࢰࢩ࢝࡟࠾ࡅࡿᢠయ⏘⏕ࢆㄏᑟࡋ㸪ࡑࡢᢠయࡀ࢚ࢰࢩ࢝㏱᫂ᖏࢆ✀≉ ␗ⓗ࡟ㄆ㆑ࡍࡿࡇ࡜ࡀ᫂ࡽ࠿࡟࡞ࡗࡓࠋ  ᮏ◊✲࡟ࡼࡾ㸪࢚ࢰࢩ࢝࡟≉␗ⓗ࡞㑊ዷ࣡ࢡࢳࣥᢠཎࡢೃ⿵ࡀ㑅ᐃࡉࢀࡓࠋ ᮏ◊✲࡛⏝࠸ࡓ᪉ἲ㸪ࡍ࡞ࢃࡕ㸪㸯㸧㏱᫂ᖏ⢾⺮ⓑ㉁ࡢ㑇ఏᏊ㓄ิࢆゎㄞࡋ㸪 ࡑࡢ୰࡛࢚ࣆࢺ࣮ࣉ࡜࡞ࡗ࡚࠸ࡿ㡿ᇦࡢ㓄ิࢆ௚✀ື≀࡟࠾ࡅࡿ┦ྠ㡿ᇦࡢ㓄 ิ࡜ẚ㍑ࡋ㸪✀≉␗ⓗ࡞࢚ࣆࢺ࣮ࣉ㡿ᇦࢆ᥎ᐃࡍࡿ㸪㸰㸧ࡑࡢ࢚ࣆࢺ࣮ࣉ㡿ᇦ ࡢ࢔࣑ࣀ㓟㓄ิ࡟ᇶ࡙࠸࡚ྜᡂ࣌ࣉࢳࢻࢆసᡂࡋච␿ࡍࡿࡇ࡜࡛ᚓࡽࢀࡓᢠయ ࢆ⏝࠸࡚㸪ᑐ㇟✀ࡸ௚✀ࡢ༸ᕢࢆ⏝࠸ࡓච␿ᰁⰍ࠾ࡼࡧయእཷ⢭㜼ᐖヨ㦂ࢆ⾜ ࠸㸪ᢠయࡢ✀≉␗ᛶ࠾ࡼࡧᶵ⬟ࢆ᳨ᰝࡍࡿ㸪࡜࠸࠺ᢠཎ㡿ᇦࡢ㑅ᐃἲࡣ㸪㑊ዷ ࣡ࢡࢳࣥ㛤Ⓨࡀᮃࡲࢀࡿ௚ࡢື≀✀࡟ࡶᛂ⏝ྍ⬟࡞᪉ἲ࡛࠶ࡿ࡜⪃࠼ࡽࢀࡿࠋ

(4)

Ꮫ ఩ ㄽ ᩥ せ ⣙

  Ặ    ྡ KOBAYASHI, Kohei

  㢟    ┠ Studies on Development of Immunocontraceptive Vaccine using Zona Pellucida Synthetic Peputide Antigen in

the Hokkaido Sika Deer (Cervus nippon yesoensis)

㸦㏱᫂ᖏ⢾⺮ⓑ㉁ྜᡂ࣌ࣉࢳࢻࢆᢠཎ࡜ࡋࡓ࢚ࢰࢩ࢝ 㑊ዷ࣡ࢡࢳࣥ㛤Ⓨ࡟㛵ࡍࡿ◊✲㸧

 Overabundance of the Hokkaido sika deer (Cervus nippon yesoensis) causes many problems, including agricultural, forestry, and ecological damage. The Japanese government has implemented deer management plans focused on shooting, but the efficiency of this method is inadequate and the problem remains serious. The development of new methods for deer population control is imperative. Thus, a form of management that incorporates both shooting and reproductive control should be considered as an effective tool for population control.

Immunocontraception is a method of inhibiting reproduction through the animal’s own immune system. In previous studies, anesthesia or immobilization was required when the immunocontraceptive vaccine was administered to wildlife. Since capture and immobilization for administration of immunocontraceptive vaccines in free-ranging populations requires much effort and high cost, the development for an effective method, that allows administration without anesthesia, is necessary for population control of wildlife. When an oral immunocontraceptive vaccine is used, both target species and non-target species can ingest the vaccine and become vaccinated. So, non-target species may vaccinated with oral vaccine. Therefore, ensuring species specificity of the vaccine to avoid affecting non-target species is a key priority in developing a immunocontraceptive vaccine in free-ranging wildlife.

The synthetic peptide antigen is candidate of immunocontraceptive antigen, because it is easy to make, and has the potential for oral administration. Antibody production against a synthetic peptide based on the B-cell epitope of porcine zona pellucida (PZP),

(5)

immuncontraception is tested.

In Chater 2, vaccine trial with the synthetic peptide based on the amino acid sequence of the B-cell epitope of PZP was conducted to elucidate antibody production against the synthetic peptide in the Hokkaido sika deer and the ability of the antibody to bind to the ZP. Production of antibodies that bind to PZP was observed. However, the antibody produced in the Hokkaido sika deer could bind to porcine ZP but not bind to deer ZP. In addition, the pregnancy of immunized deer was observed. Thus, the present results suggest that the B-cell epitope of ZP that has a role in fertilization is different between porcine and the Hokkaido sika deer. This finding suggests the potential for the development of species specific immunocontraceptive vaccine using the synthetic peptide based on the amino acid sequence of B-cell epitope.

In Chapter 3, the DNA sequence of the Hokkaido sika deer zona pellucida and the difference between porcine and sika deer was revealed. Sequence of deer DNA of the area in which used for synthetic peptide in vaccine trial showed 88% homology to porcine. The synthetic peptide based on amino acid sequence of B-cell epitope of sika deer ZP1 was vaccinated in rabbit. The ability of the antibody to bind zona pellucida and species specificity was examined by immunohistochemistry using porcine, bovine, and deer ovary. Antibody against the synthetic peptide based on the B-cell epitope in sika deer ZP was not able to bind porcine and bovine ZP. In contrast, the antibody was able to bind sika deer ZP. These results suggest the species specificity of the antibody against the synthetic peptide based on the amino acid sequence of the B-cell epitope of ZP. Therefore, the synthetic peptide based on the amino acid sequence of the B-cell epitope which is different between species seems to be a target of species specific immunocontraceptive vaccine.

In Chapter 4, the synthetic peptide based on the amino acid sequence of sika deer ZP B-cell epitope was vaccinated on three captive sika deer to examine the production and function of the antibody against the synthetic peptide based on auto-antigen. In the result, the antibody production was observed. The ability to bind sika deer ZP and

(6)

species specificity was same as antibody from rabbit immunized in Chapter 3. Therefore, the synthetic peptide based on the amino acid sequence of sika deer ZP B-cell epitope was evaluated as candidate antigen of sika deer specific immunocontraceptive vaccine. In addition, the finding that the synthetic peptide based on specific auto-antigen is able to induce the production of the antibody which has ability to bind own ZP is showing the method of antigen selection for develop species specific immunocontraceptive vaccine. The function and species specificity of the antibody which is produced in the Hokkaido sika deer is similar to the antibody which is produced in rabbit. Therefore, functioning of the antibody obtained from Hokkaido sika deer could be evaluated using antibody obtained from rabbits immunized with the synthetic peptide.

The present study found that the synthetic peptide based on amino acid sequence of own ZP seems to be the species-specific antigen using for immunocontraception of the Hokkaido sika deer. On the bases of the present results, the following is proposed as an effective method for the generation of a species-specific antigen for the immunocontraception: 1) designing the synthetic peptide based on the amino acids sequence of a target antigen that is critical for fertilization; 2) immunization of rabbits for preliminary evaluation of antibody function and immunohistochemical evaluation of the ability of the antibody to bind to the zona pellucida, using ovaries of the target species.

参照

関連したドキュメント

Effect of Porcine Placental Extract on Collagen Production in Human Skin Fibroblasts In Vitro.. Chikako Yoshikawa 1 , Fumihide Takano 2,3 , Yasuhito Ishigaki 4 , Masahiko Okada 1

Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Phase I/II trial of the safety and efficacy of shark cartilage in

 哺乳類のヘモグロビンはアロステリック蛋白質の典

If Φ is a small class of weights we can define, as we did for J -Colim, a2-category Φ- Colim of small categories with chosen Φ-colimits, functors preserving these strictly, and

Eskandani, “Stability of a mixed additive and cubic functional equation in quasi- Banach spaces,” Journal of Mathematical Analysis and Applications, vol.. Eshaghi Gordji, “Stability

By an inverse problem we mean the problem of parameter identification, that means we try to determine some of the unknown values of the model parameters according to measurements in

We present sufficient conditions for the existence of solutions to Neu- mann and periodic boundary-value problems for some class of quasilinear ordinary differential equations.. We

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: